Objective: To systemically evaluate the effectiveness and safety of Cinobufacini injection for lung cancer. Method: We searched The Cochrane Central Register of Controlled Trials (CCTR)

PubMed

CNKI

CBM

VIP databases up to Dce. 2014. The methodological quality assessment and data extraction of the included studies were conducted by two reviewers independently according to the inclusion and exclusion criteria. Meta-analysis was performed for homogeneous studies using RevMan 4.2.10 software after subgroup analysis of the measurement indicators and intervention measures. Result: A total of 17 studies involving 1279 patients were included. None of the studies mentioned allocation concealment method and no blinding method was performed. Conclusion: In the treatment of lung cancer

the combination of cinobufacini injection and western medicine is superior to western medicine alone for the long-term survival rate

quality of life and short-term efficacy.